Shopping Cart
- Remove All
Your shopping cart is currently empty
Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $52 | In Stock | |
| 5 mg | $123 | In Stock | |
| 10 mg | $197 | In Stock | |
| 25 mg | $357 | In Stock | |
| 50 mg | $569 | In Stock | |
| 100 mg | $786 | In Stock | |
| 200 mg | $1,090 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $176 | In Stock |
| Description | Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production. |
| Targets&IC50 | TPO receptor:3.3 nM (EC50) |
| In vivo | Avatrombopag is treatment of thrombocytopenia in patients with CLD who are scheduled to undergo a procedure[1]. |
| Synonyms | YM477, E5501, AKR-501 |
| Molecular Weight | 649.65 |
| Formula | C29H34Cl2N6O3S2 |
| Cas No. | 570406-98-3 |
| Smiles | OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1 |
| Relative Density. | 1.440 g/cm3 |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: < 1 mg/mL (insoluble or slightly soluble) |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.